SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-001043
Filing Date
2021-07-19
Accepted
2021-07-19 16:15:46
Documents
15
Period of Report
2021-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620806_8k-immunic.htm   iXBRL 8-K 24620
2 e620806_ex1-1.htm EX-1.1 294769
3 e620806_ex5-1.htm EX-5.1 10358
7 GRAPHIC image.jpg GRAPHIC 4764
  Complete submission text file 0001193805-21-001043.txt   586603

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imux-20210715.xsd EX-101.SCH 3118
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20210715_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20210715_pre.xml EX-101.PRE 22382
8 EXTRACTED XBRL INSTANCE DOCUMENT e620806_8k-immunic_htm.xml XML 3695
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 211098067
SIC: 2834 Pharmaceutical Preparations